Jasminka Djelilović-Vranić

Efficacy and Safety of Masitinib in Progressive Forms of Multiple Sclerosis

Patrick Vermersch, Luís Brieva, Robert J. Fox, Friedemann Paul et autres

BACKGROUND AND OBJECTIVES: Masitinib is a selective tyrosine kinase inhibitor, targeting innate immune cells (mast cells and microglia) that are involved in the pathophysiology of progressive multiple sclerosis (MS). Study AB07002 assessed oral masitinib in patients with progressive MS who were progressing …

fr, es, pl, de (code pays fourni par la source)

Epilepsy and multiple sclerosis

Jasminka Djelilović-Vranić, Amina Nakičević

ba (code pays fourni par la source)

Seasonal occurrence of Guillain-Barre syndrome over a 5-year period

Edina Djozic, J. Kulenovic, Jasminka Djelilović-Vranić, A. Djozic-Sahmic

ba (code pays fourni par la source)

The frequency of carpal tunnel syndrome in patients on hemodialysis

Miro Denišlič, Emir Tupković, Jasminka Djelilović-Vranić, Azra Alajbegović et autres

ba, si (code pays fourni par la source)

Follow-up of Vasospasm by Transcranial Doppler Sonography (TCD) in Subarachnoid Hemorrhage (SAH)

Jasminka Djelilović-Vranić, Vanja Bašić-Kes, Merita TiricCampara, Edina Djozic et autres

INTRODUCTION: Subarachnoid hemorrhage (SAH)represents hemorrhage in the space between arachnoidea and pia mater, due to aneurysm burst, spontaneously or as a consequence of trauma. It is condition that occurs more common in women than men, and its most common complications are rebleeding …

ba, hr (code pays fourni par la source)

Gender Differences in Biochemical and Electroneurographic Parameters of Median and Ulnar Nerve

Merita TiricCampara, Emir Tupković, Miro Denišlič, Mirza Biščević et autres

INTRODUCTION: In this article are demonstrated differences in the aspects of the metabolic syndrome (MSy) between genders, as well as the association of MSy and neuropathy. THE AIM: The aim of our study was that in patients with newly discovered metabolic syndrome …

ba, si (code pays fourni par la source)

Marriage of Epileptic Patients

Azra Alajbegović, Jasminka Djelilović-Vranić, Salem Alajbegović, Lejla Alajbegović

Cutaneous Silent Period in the Evaluation of Small Nerve Fibres

Merita TiricCampara, Miro Denišlič, Jasminka Djelilović-Vranić, Azra Alajbegović et autres

INTRODUCTION: High intensity cutaneous stimulus transiently suppresses tonic voluntary muscle activity resulting in cutaneous silent period (CSP). AIM: The aim of our study was to evaluate the normal values of an onset latency L1, a late latency L2 and a duration of …

si, ba, kw (code pays fourni par la source)

Post Stroke Depression

Azra Alajbegović, Jasminka Djelilović-Vranić, Salem Alajbegović, Amina Nakičević et autres

INTRODUCTION: Comorbidity of depression and stroke significantly reduces the quality of life of patients after the stroke. Squeal after stroke also determines the quality of life and have impact on the occurrence of depression after the stroke. In our study we investigated …

ba (code pays fourni par la source)

Incidence of multiple sclerosis in the region of Sarajevo before and after the war events

Jasminka Djelilović-Vranić, Azra Alajbegović, Senka Salcic, Edina Djozic et autres

ba (code pays fourni par la source)

Poststroke depression

Azra Alajbegović, Jasminka Djelilović-Vranić, Ljubica Todorović, Salem Alajbegović et autres

ba (code pays fourni par la source)

The Effects of Dipeptidyl Peptidase-4 Inhibitors in Treatment of Obese Patients with Type 2 Diabetes

Zelija Velija-Ašimi, Sebija Izetbegović, Jasenko Karamehić, Jozo Ćorić et autres

INTRODUCTION: Dipeptidyl peptidase-4 (DPP-4) inhibitors are a new class of antihyperglycemic drugs that block degradation ofincretin hormones. GOAL: To assess the effects oftreatment with DPP-4 inhibitors on glucoregulation and body weight in obese patients with type 2 diabetes mellitus. PATIENTS AND METHODS: …

ba (code pays fourni par la source)